Furthermore, studies have demonstrated that dominant negative forms of the TLR2 adapter molecules myeloid differentiation primary response gene 88 (MyD88) and MAL/TIRAP inhibit pro-inflammatory cytokine production in RA synoviocytes [8]. This evidence concerns the gene MYD88 and rheumatoid arthritis.